ResearchMoz added Latest Research Report titled ” United States Off-Label Drugs Market & Forecast ” to it’s Large Report database.
Off–label prescribing of medicines is prevalent worldwide because it gives freedom to physicians to apply new therapeutic options based on the latest evidence. Although physicians may lawfully prescribe approved Drugs for any use consistent with available scientific data and proper medical practice, but unfortunately, this is done without adequate scientific data. Often, when the best available therapeutic option fails, patients demand new approach or new treatment which ultimately leads to off–label uses.
Off–label use is very common in United States. United States Off–label Drugs demand has grown at a fast pace in the past decade and likely to grow in the forecasting period. It is likely that United States off–label market will cross the figure of 60 Billion by the year 2020. Central Nervous System (CNS) and Cancer off–label Drugs controls the largest market share of the total US off–label Drugs market. Anti–Infectives Off–Label Drugs Market and Anti–Asthmatics Off–Label Drugs together are expected to control close to 35% market share by 2020.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=266742
Renub Research study titled “United States Off–Label Drugs Market & Forecast” report provides a comprehensive analysis of the emerging Off–Label Drugs market. The report also entails commonly prescribed Off–Label Drugs, Perspective of Physicians, Patients, Pharmaceutical Companies and Regulatory Authorities, Off–label Promotion Settlements under the False Claims Act. The report also studies Drivers and Challenges of United States Off–Label Drugs market. This 67 page report with 16 Figures and 1 Table studies 6 Off–Label Drugs Segment.
The 6 Off–Label Drugs Segment Covered in the Report are as Follows:
Cancer Off–Label Drugs
Central Nervous System (CNS) Off–Label Drugs
Anti–Asthmatics Off–Label Drugs
Anti–Allergies Off–Label Drugs
Anti–Hypertensives Off–Label Drugs
Anti–Infectives Off–Label Drugs
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html
Table of Content
1. Executive Summary
2. United States Off–Label Drugs Market & Forecast
3. United States Off–Label Drugs Market Share & Forecast
4. United States Off–Label Drugs Market – Segment wise
4.1 United States – Cancer Off–Label Drugs Market & Forecast
4.2 United States – Central Nervous System (CNS) Off–Label Drugs Market & Forecast
4.3 United States – Anti–Asthmatics Off–Label Drugs Market & Forecast
4.4 United States – Anti–Allergies Off–Label Drugs Market & Forecast
4.5 United States – Anti–Hypertensives Off–Label Drugs Market & Forecast
4.6 United States – Anti–Infectives Off–Label Drugs Market & Forecast
5. Drugs Commonly Prescribed Off–Label
6. Off–Label Use of Medicine & Different Perspectives
6.1 Physicians Perspective
6.1.1 Physicians’ Liability for Off–Label Prescriptions
6.2 Patients Perspective
6.3 Perspective of the Pharmaceutical Companies
6.4 Perspective of Regulatory Agencies
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Albany NY, United States – 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/